ArticleBlood2021
Association of unbalanced translocation der(1;7) with germline GATA2 mutations.
Open access · hybridAbstract readLetter
In one paragraph
Article in Blood, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.Cancer medicine · 2024Pooled it
- Reduced STAG2 expression in myelodysplastic neoplasms and acute myeloid leukemia myelodysplasia-related: a potential biomarker associated with aneuploidy and disease progression.Frontiers in cell and developmental biology · 2026Article
- Review
- Germline and somatic genetic landscape of pediatric myelodysplastic syndromes.Haematologica · 2025Review
- Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.Blood cancer journal · 2025Article
- Case Report: GATA2 deficiency in two families with novel frameshift variants highlighting phenotypic diversity and need for early diagnosis.Frontiers in immunology · 2025Article
- Malignant progression of preleukemic disorders.Blood · 2024Review
- Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.Haematologica · 2024Article
- Clonal evolution in inherited marrow failure syndromes predicts disease progression.Hematology. American Society of Hematology. Education Program · 2023Review
- Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.The Lancet. Haematology · 2023Review
- How I diagnose myeloid neoplasms with germline predisposition.American journal of clinical pathology · 2023Article
- GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.Current hematologic malignancy reports · 2023Review
- The spectrum of GATA2 deficiency syndrome.Blood · 2023Article
- Article
- Germline and somatic drivers in inherited hematologic malignancies.Frontiers in oncology · 2023Review
- GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.British journal of haematology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
47 authors at 20 institutions in 20 countries.
Emilia J KozyraDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.ORCID 0000-0003-1107-8818
Gudrun GöhringDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
Dennis D HicksteinImmune Deficiency-Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Katherine R CalvoDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Courtney D DiNardoDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-9003-0390
Michael DworzakSt. Anna Childreńs Hospital and Cancer Research Institute, Pediatric Clinic, Medical University of Vienna, Vienna, Austria.
Valerie de HaasDutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands.ORCID 0000-0003-0339-6816
Jan StarýDepartment of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
Henrik HasleDepartment of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark.
Akiko ShimamuraDana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, MA.ORCID 0000-0002-4683-9958
Mark D FlemingDepartment of Pathology, Boston Children's Hospital, Boston, MA.ORCID 0000-0003-0948-4024
Hiroto InabaDepartment of Oncology and.
Sara LewisDepartment of Hematology, St Jude Children's Research Hospital, Memphis, TN.
Amy P HsuLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-6841-2122
Steven M HollandLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Danielle E ArnoldImmune Deficiency-Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD.ORCID 0000-0001-7501-806X
Cristina MecucciDepartment of Medicine, Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy.ORCID 0000-0002-1623-0148
Siobán B KeelDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA.
Alison A BertuchDepartment of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX.
Kiran TawanaDepartment of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom.
Shlomit BarzilaiPediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel.
Shinsuke HirabayashiDepartment of Pediatrics and.ORCID 0000-0001-7961-0968
Masahiro OnozawaDepartment of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan.ORCID 0000-0001-9267-2864
Shaohua LeiDepartment of Computational Biology, St Jude Children's Research Hospital, Memphis, TN.
Helena AlaizHematology Department, Oncology Institute Francisco Gentil, Lisbon, Portugal.
Hajnalka AndrikovicsLaboratory of Molecular Diagnostics, Central Hospital of Southern Pest, Budapest, Hungary.
David BettsNational Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Berna H BeverlooDutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands.
Jochen BuechnerDepartment of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-5848-4501
Martin ČermákDepartment of Genetics, The National Institute of Oncology, Bratislava, Slovakia.ORCID 0000-0002-9949-0163
José CerveraDepartment of Hematology, Genetics Unit, Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Olga HausDepartment of Clinical Genetics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland.
Kirsi JahnukainenNew Children's Hospital, Pediatric Research Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Kalliopi N ManolaDepartment of Biodiagnostic Sciences and Technologies, The Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety (INRASTES), National Centre for Research 'Demokritos', Athens, Greece.
Karin NebralLabdia Labordiagnostik GmbH, Clinical Genetics, Vienna, Austria.ORCID 0000-0002-0548-541X
Francesco PasqualiMedical Genetics, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Joelle TchindaLaboratory for Oncology, University Children's Hospital Zürich, Zürich, Switzerland.
Dominik TurkiewiczDepartment of Pediatrics, Section of Pediatric Oncology, Hematology, Immunology and Nephrology, Skåne University Hospital, Lund, Sweden.
Nadine Van RoyCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Zuzana ZemanovaCenter of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine of Charles University, Prague, Czech Republic; and.
Victor B PastorDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.
Brigitte StrahmDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.ORCID 0000-0002-6086-130X
Peter NoellkeDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.ORCID 0000-0002-0281-4732
Charlotte M NiemeyerDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.ORCID 0000-0003-3856-7937
Brigitte SchlegelbergerDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-5256-1270
Ayami YoshimiDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.
Marcin W WlodarskiDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and.ORCID 0000-0001-6638-9643
St. Jude Children's Research Hospital · USCharles University · CZMedizinische Hochschule Hannover · DENational Cancer Institute · USNational Institutes of Health · USAarhus University Hospital · DKAddenbrooke's Hospital · GBBaylor College of Medicine · USBoston Children's Hospital · USCentro de Investigación Biomédica en Red de Cáncer · ESChildren's Health Ireland at Crumlin · IEDana-Farber/Boston Children's Cancer and Blood Disorders Center · USErasmus MC · NLGerman Cancer Research Center · DEGhent University Hospital · BEHokkaido University · JPInstituto Português de Oncologia Francisco Gentil · PTKarolinska University Hospital · SENational Centre of Scientific Research "Demokritos" · GRNational Institutes of Health Clinical Center · US
Funding
Systems Biology of Bone Marrow Failure and MDS for Precision MedicineRC2DK122533 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FIGUEROA, MARIA EUGENIA, FLEMING, MARK D · 2019 to 2023
$6.4MNIDDK NIH HHS RC2 DK122533
Abstract
PubMed holds no abstract for this paper.
Indexed as
Germ-Line MutationAdolescentAdultChildFemaleGATA2 Transcription FactorHumansMaleMiddle AgedMyelodysplastic SyndromesTranslocation, GeneticYoung AdultGATA2 protein, humanGATA2 Transcription Factor
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.